Carbon Biosciences logo

Carbon Biosciences jobs and careers

Lexington, MA, United States

About Carbon Biosciences

Carbon Biosciences is expanding the therapeutic potential of gene therapy through its proprietary platform which leverages novel parvoviruses that have been pressure tested by nature to target specific tissues, carry a larger cargo, with minimal neutralizing immunity and the potential to re-dose. Founded by Longwood Fund and gene therapy pioneers John F. Engelhardt, Ph.D., and Robert M. Kotin, Ph.D., Carbon is expanding the gene therapy toolbox for the treatment of the world’s most devastating and difficult to treat diseases.

Founded in 2021 by Joel Schneider and Robert Kotin.

Founded
2021
Employees
11 to 50
Total funding
$38M
Headquarters
Lexington

Leadership

The top of Carbon Biosciences's org chart, with how many people report into each leader.

JSPhoto of Joel Schneider

Joel Schneider

President and Chief Executive Officer

10 reports

SDPhoto of Sebastian Aguirre Kozlouski, Ph.D.

Sebastian Aguirre Kozlouski, Ph.D.

Co-Founder, Vice President, Head of Platform Development

5 reports

BCPhoto of Brian Collins

Brian Collins

Senior Vice President Technology Development

KD

Keith Dewedoff

Chief Financial Officer

SD

Steve Dipalma

Chief Financial Officer

ALPhoto of Amy Lurier

Amy Lurier

Sr. Vice President, Talent & People

Board

BDPhoto of Bev Davidson

Bev Davidson

Scientific Advisor

ATPhoto of Adrian Thrasher

Adrian Thrasher

Scientific Advisor

CSPhoto of Chen Schor

Chen Schor

Chairman of the Board

JCPhoto of Jay Chiorini

Jay Chiorini

Scientific Advisor

DSPhoto of David Steinberg

David Steinberg

Director

DYPhoto of Derek Yoon

Derek Yoon

Director

Jobs at Carbon Biosciences

No open positions right now. Explore more companies on TheJobsMap.